Device Trial Radar · NCT01831544
A Clinical Trial to Evaluate the HeartWare MVAD® System (MVAdvantage)
Last checked: Nov 19, 2026Latest source record: Sep 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
11
Actual
Start
Jul 14, 2015
Primary completion
Sep 1, 2015
Study completion Feb 16, 2017
Sponsor
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
- Sponsor type
- Industry
- First posted
- Apr 15, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This multi-center, prospective, non-randomized, single-arm trial will investigate the safety and performance of the HeartWare® Miniaturized Ventricular Assist Device (MVAD®) system over 24 months in subjects with advanced heart failure
Conditions
- Heart Failure
Interventions
HeartWare MVAD® SystemDevice
The HeartWare MVAD® System consists of a small, wearless, continuous flow pump and associated surgical tools and implant accessories, peripheral components which control and power the system, and a monitor which allows for programming and monitoring of the system
Primary outcomes
What the sponsor says the trial is designed to measure.
- SurvivalTime frame: Six month
Locations
11 sites in 5 countries. Site status is shown where the registry gives one.
St. Vincents Hospital
Darlinghurst, Australia
Medical University AKH Vienna
Vienna, Austria
Hospitalier Pitié-Salpétrière
Paris, France
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.